Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q2 2019 Earnings

7MayConfirmed

Q3 2018

Q4 2018

Q1 2019

Q2 2019

-0.23

-0.15

-0.07

0.01

Details

Expected EPS

N/A

Actual EPS

0.01

Surprise EPS

0.01

Surprise Percent

+∞%

Description

Halozyme Therapeutics (HALO) has reported earnings of 0.01 per share for Q2 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.